Y-mAbs Therapeutics, Inc. (YMAB)
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
Address
230 PARK AVENUE
NEW YORK, NY 10169
Founded
2015
Number of Employees
100
Website
http://www.ymabs.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)